Riskpilot← Back to searchSign inGet full accessMEDISAM AS
ASActiveOrg 925257117Vangsvegen 163A, Leilighet 708, 2321 HamarGeneral medical practice activities · NACE 8621Est. 20201 employees
Revenue 2024
NOK 4,1M
+19% vs 2023
EBITDA margin
46.9%
+45% vs 2023
Equity ratio
22.4%
Financial strength
Net profit 2024
NOK 1,3M
+54% vs 2023
| Revenue | NOK 4,1M | +19% |
| EBITDA | NOK 1,9M | +45% |
| Net profit | NOK 1,3M | +54% |
| Total assets | NOK 615K | -55% |
| Equity | NOK 138K | +129% |
| Employees | 1 | — |
Legal name
MEDISAM AS
Org number
925257117
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. juni 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Medisinsk behandling, kurs-, foredrags- og undervisningsvirksomhet, utarbeidelse av spesialisterklæringer og sakkyndige oppdrag, konsulentvirksomhet og forvaltning av selskapets kapital og ressurser i form av investeringsvirksomhet, deltakelse i andre selskaper, finansforvaltning, kjøp, drift, oppføring og rehabilitering av fast eiendom.
Address
Vangsvegen 163A, Leilighet 708, 2321 Hamar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 278 | 3 065 | 3 380 | 3 435 | 4 081 |
| Staff expenses | −7 | −15 | −322 | −296 | −243 |
| EBITDA | 662 | 1 553 | 1 636 | 1 315 | 1 913 |
| Depreciation & amort. | −125 | −275 | −222 | −222 | −222 |
| EBIT | 537 | 1 278 | 1 413 | 1 093 | 1 691 |
| Net financials | 0 | −0 | −1 | −2 | −20 |
| Profit before tax | 537 | 1 278 | 1 413 | 1 092 | 1 671 |
| Tax | 112 | 287 | 326 | 264 | 394 |
| Net profit | 425 | 991 | 1 087 | 828 | 1 278 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 043 | 1 946 | 2 020 | 1 382 | 615 |
| Equity | 55 | 45 | 32 | 60 | 138 |
| Long-term debt | 1 497 | 602 | 445 | 206 | 0 |
| Short-term debt | 491 | 1 299 | 1 542 | 1 116 | 478 |
| Total debt | 1 988 | 1 901 | 1 988 | 1 322 | 478 |
EBITDA margin
46.9%
This company
15.8%
Market median
+197% vs market
20202024
Equity ratio
22.4%
This company
38.2%
Market median
-41% vs market
20202024
Return on equity
928.5%
This company
18.4%
Market median
+4946% vs market
20202024
Net profit margin
31.3%
This company
8.1%
Market median
+286% vs market
20202024
Asset turnover
6.63×
This company
1.12×
Market median
+492% vs market
20202024
Debt / equity
3.47×
This company
0.62×
Market median
-460% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SR Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rahmanpour Holding As
MEDISAM AS Board members of MEDISAM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sam Rahmanpour | Chief Executive Officer | 0 companies |